Biosimilar Competition for Humira Is Here: Signs of Hope Despite Early Hiccups
Arthritis Rheumatol
.
2023 Aug;75(8):1325-1327.
doi: 10.1002/art.42520.
Epub 2023 May 24.
Authors
Benjamin N Rome
1
,
Aaron S Kesselheim
1
Affiliation
1
Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts.
PMID:
37026489
DOI:
10.1002/art.42520
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
Adalimumab
Antirheumatic Agents*
Biosimilar Pharmaceuticals*
Double-Blind Method
Hiccup*
Humans
Substances
Adalimumab
Biosimilar Pharmaceuticals
Antirheumatic Agents